Drug Detail

Information about NN3201

Generic Name
IND	NN3201
Brand Name (US)
Manufacturer	Novelty Nobility
Drug Type	monoclonal antibody
Delivery	Intravenous
Approval Status	Phase 1
Indications	Ckit positive cancers
Overall Strategy	Modulate microtubule dynamics
Strategy	KIT Anti-body Drug Conjugate
Drug Category	SDH-directed

Links
	Mol Cancer Ther 9/2025 "Preclinical Anti-Tumor Efficacy of a Novel Anti-c-Kit Antibody Drug Conjugate, NN3201, in c-Kit Positive Tumors Available to Purchase"

Trials of this drug
	A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Trial results